CLINICAL_TRIALS
trial_result
· 2026-02-25
Clinical Trial Update: Sintilimab in Cancer of Unknown Primary [Phase 2]
Summary
Phase 2 trial of sintilimab in cancer of unknown primary has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer of Unknown Primary Site | Phase 2 | Status: COMPLETED | Results posted: 2026-02-25